These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19081855)

  • 1. Highlights and prizes of an international meeting.
    Grammaticos PC
    Hell J Nucl Med; 2008; 11(3):146-8. PubMed ID: 19081855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
    Høilund-Carlsen PF
    Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host immune response determines visceral hyperalgesia in a rat model of post-inflammatory irritable bowel syndrome.
    Adam B; Tsopelas C; Liebregts T; Bartholomeusz FD; Holtmann G
    J Gastroenterol; 2013 Oct; 48(10):1119-27. PubMed ID: 23307099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors.
    Strauss LG; Koczan D; Klippel S; Pan L; Cheng C; Willis S; Haberkorn U; Dimitrakopoulou-Strauss A
    J Nucl Med; 2008 Aug; 49(8):1238-44. PubMed ID: 18632818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of gene expression on 18F-FDG kinetics; a new chapter for diagnostic nuclear medicine.
    Strauss LG; Dimitrakopoulou-Strauss A
    Hell J Nucl Med; 2009; 12(1):2-4. PubMed ID: 19330172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is (18)F-FDG PET really a promising marker for clinically relevant atherosclerosis?
    Brammen L; Palumbo B; Lupattelli G; Sinzinger H
    Hell J Nucl Med; 2014; 17(1):62-3. PubMed ID: 24701595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of
    Zheng J; Miao W; Huang C; Lin H
    Ann Nucl Med; 2017 Jul; 31(6):486-494. PubMed ID: 28474165
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Elvas F; Boddaert J; Vangestel C; Pak K; Gray B; Kumar-Singh S; Staelens S; Stroobants S; Wyffels L
    J Nucl Med; 2017 Apr; 58(4):665-670. PubMed ID: 27879368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis imaging probe predicts early chemotherapy response in preclinical models: A comparative study with 18F-FDG PET.
    Song S; Xiong C; Lu W; Ku G; Huang G; Li C
    J Nucl Med; 2013 Jan; 54(1):104-10. PubMed ID: 23283564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab.
    Vangestel C; Van de Wiele C; Van Damme N; Staelens S; Pauwels P; Reutelingsperger CP; Peeters M
    J Nucl Med; 2011 Nov; 52(11):1786-94. PubMed ID: 22045708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
    Storch D; Béhé M; Walter MA; Chen J; Powell P; Mikolajczak R; Mäcke HR
    J Nucl Med; 2005 Sep; 46(9):1561-9. PubMed ID: 16157541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG kinetics and gene expression in giant cell tumors.
    Strauss LG; Dimitrakopoulou-Strauss A; Koczan D; Bernd L; Haberkorn U; Ewerbeck V; Thiesen HJ
    J Nucl Med; 2004 Sep; 45(9):1528-35. PubMed ID: 15347720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of tumor sensitivity to photodynamic therapy and early evaluation of treatment effect by nuclear medicine techniques.
    Liu J; Ogawa M; Sakai T; Takashima M; Okazaki S; Magata Y
    Ann Nucl Med; 2013 Aug; 27(7):669-75. PubMed ID: 23666558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scintigraphic imaging of experimental colitis with technetium-99m-infliximab in the rat.
    Tsopelas C; Penglis S; Ruskiewicz A; Bartholomeusz DL
    Hell J Nucl Med; 2006; 9(2):85-9. PubMed ID: 16894410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer.
    Robu S; Schottelius M; Eiber M; Maurer T; Gschwend J; Schwaiger M; Wester HJ
    J Nucl Med; 2017 Feb; 58(2):235-242. PubMed ID: 27635024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy.
    Dimitrakopoulou-Strauss A; Strauss LG; Burger C; Rühl A; Irngartinger G; Stremmel W; Rudi J
    J Nucl Med; 2004 Sep; 45(9):1480-7. PubMed ID: 15347714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
    Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.